SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: John R. Sashko who wrote (1732)4/28/1998 12:11:00 AM
From: needawin  Read Replies (1) | Respond to of 9523
 
Viagra - the subject of Nightline tonight. Overall so far very positive things being said. Also I understand AG Edwards raised their price target on PFE to $150 per share today! With todays sales numbers tomorrow should see a rebound. This is a break-through product and I believe Ableson will be wrong again. Comments?



To: John R. Sashko who wrote (1732)4/28/1998 10:13:00 PM
From: Solid  Respond to of 9523
 
John-

I concur and appreciate your opinion. A very good friends Dad was a VP of marketing for Coty, a division of Pfizer. Even though not a fan of the Co. from an employees perspective (bottom line or bust at ALL cost) he was and is very adamant that pfe is a STRONG HOLD, with only normal dips but much higher price coming for stock.

Thanks for sharing your thoughts.

Solid


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News